Table 5.
Antithrombotics (B01) (n=1991)* |
Lipid-lowering (C10) (n=1954)* |
Thyroid meds (H03) (n=456)* |
Respiratory inhalers (R03) (n=757)* |
|||||
Unadjusted OR (95% CI, p value) | Adjusted OR (95% CI, p value) | Unadjusted OR (95% CI, p value) | Adjusted OR (95% CI, p value) | Unadjusted OR (95% CI, p value) | Adjusted OR (95% CI, p value) | Unadjusted OR (95% CI, p value) | Adjusted OR (95% CI, p value) | |
Medication listed on discharge summary | 1.29 (0.95 to 1.76), p=0.11 | 1.34 (0.97 to 1.87), p=0.08 | 1.40 (0.99 to 1.97), p=0.06 | 1.64 (1.15 to 2.36), p=0.01 | 1.86 (0.77 to 4.43), p=0.16 | 1.76 (0.70 to 4.42), p=0.23 | 2.74 (1.57 to 4.78), p<0.001 | 2.97 (1.68 to 5.25), p<0.001 |
Age (years) | 0.98 (0.96 to 1.00), p=0.03 | 0.98 (0.96 to 1.00), p=0.08 | 0.96 (0.94 to 0.98), p<0.001 | 0.95 (0.93 to 0.98), p<0.001 | 0.96 (0.91 to 1.02), p=0.16 | 0.96 (0.91 to 1.02), p=0.16 | 0.97 (0.94 to 1.01), p=0.12 | 0.96 (0.93 to 1.00), p=0.03 |
Female vs male | 1.02 (0.76 to 1.38), p=0.90 | 0.97 (0.70 to 1.33), p=0.84 |
1.14 (0.84 to 1.56), p=0.39 | 1.15 (0.83 to 1.59), p=0.41 | 1.34 (0.52 to 3.49), p=0.54 | 1.35 (0.49 to 3.73), p=0.57 | 0.93 (0.58 to 1.50), p=0.77 | 0.87 (0.53 to 1.43), p=0.59 |
Insurance type Private vs GMS/DVC patients | 0.18 (0.13 to 0.26), p<0.001 | 0.18 (0.12 to 0.27), p<0.001 | 0.19 (0.12 to 0.28), p<0.001 | 0.17 (0.11 to 0.27), p<0.001 | 0.10 (0.04 to 0.26), p<0.001 | 0.10 (0.04 to 0.26), p<0.001 | 0.26 (0.14 to 0.50), p<0.001 | 0.26 (0.13 to 0.49), p<0.001 |
Number of repeat drug classes | 1.04 (1.00 to 1.09), p=0.06 | 1.04 (0.99 to 1.09), p=0.11 | 0.99 (0.94 to 1.03), p=0.49 | 1.00 (0.96 to 1.06), p=0.86 | 1.06 (0.95 to 1.18), p=0.30 | 1.10 (0.96 to 1.26), p=0.18 | 1.07 (10.01 to 1.13), p=0.03 | 1.08 (1.00 to 1.15), p=0.06 |
Charlson score (≥1 vs 0) |
1.14 (0.84 to 1.54), p=0.40 | 1.08 (0.79 to 1.49), p=0.63 | 0.76 (0.55 to 1.04), p=0.09 | 0.79 (0.56 to 1.11) p=0.18 | 1.06 (0.46 to 2.40), p=0.90 | 0.82 (0.33 to 2.03), p=0.67 | 0.98 (0.61 to 1.58), p=0.94 | 0.86 (0.52 to 1.45), p=0.55 |
No of consultations in enrolment period | 1.01 (0.99 to 1.03), p=0.19 | 1.00 (0.99 to 1.02), p=0.74 | 0.99 (0.97 to 1.01), p=0.22 | 0.99 (0.97 to 1.01), p=0.16 | 1.01 (0.97 to 1.06), p=0.63 | 0.99 (0.94 to 1.04), p=0.63 | 1.02 (1.00 to 1.05), p=0.07 | 1.02 (0.98 to 1.04), p=0.41 |
Adjusted model includes gender, age, insurance type, Charlson Index, number of repeat drugs, number of consultations in the enrolment period.
DVC, doctor visit card; GMS, general medical services; GP, general practitioner.